Literature DB >> 22872848

Reconstruction of a severely crushed leg with interpositional vessel grafts and latissimus dorsi flap.

Chan Woo Park1, Youn Hwan Kim, Kyu Tae Hwang, Jeong Tae Kim.   

Abstract

We present a case of a near total amputation at the distal tibial level, in which the patient emphatically wanted to save the leg. The anterior and posterior tibial nerves were intact, indicating a high possibility of sensory recovery after revascularization. The patient had open fractures at the tibia and fibula, but no bone shortening was performed. The posterior tibial vessels were reconstructed with an interposition saphenous vein graft from the contralateral side and a usable anterior tibial artery graft from the undamaged ipsilateral distal portions. The skin and soft tissue defects were covered using a subatmospheric pressure system for demarcating the wound, and a latissimus dorsi myocutaneous free flap for definite coverage of the wound. At 6 months after surgery, the patient was ambulatory without requiring additional procedures. Replantation without bone shortening, with use of vessel grafts and temporary coverage of the wound with subatmospheric pressure dressings before definite coverage, can shorten recovery time.

Entities:  

Keywords:  Limb salvage; Negative-pressure wound therapy; Vascular grafting

Year:  2012        PMID: 22872848      PMCID: PMC3408290          DOI: 10.5999/aps.2012.39.4.417

Source DB:  PubMed          Journal:  Arch Plast Surg        ISSN: 2234-6163


  9 in total

1.  Crossover replantation and fillet flap coverage of the stump after ectopic implantation: a case of bilateral leg amputation.

Authors:  A Kayikçioğlu; G Ağaoğlu; S Nasir; A Keçik
Journal:  Plast Reconstr Surg       Date:  2000-09       Impact factor: 4.730

2.  Replantation of a crush amputation of distal tibia followed by lengthening with Ilizarov circular external fixator: two-year follow-up.

Authors:  Mustafa Nişanci; Ergin Er; Cemil Yildiz; Murat Türegün; Sabri Atealp; Mustafa Sengezer
Journal:  Microsurgery       Date:  2002       Impact factor: 2.425

3.  Replantation of severed foot at the chopart joint: a case report.

Authors:  Shogo Nagamatsu; Kenshi Sakayama; Junji Kamogawa; Hiroki Nakaoka; Koji Hashimoto; Haruyasu Yamamoto
Journal:  Foot Ankle Int       Date:  2009-12       Impact factor: 2.827

4.  Infrapopliteal lower extremity replantation.

Authors:  Pedro C Cavadas; Luis Landín; Javier Ibáñez; Ignacio Roger; Peter Nthumba
Journal:  Plast Reconstr Surg       Date:  2009-08       Impact factor: 4.730

5.  Limb salvage versus amputation. Preliminary results of the Mangled Extremity Severity Score.

Authors:  D L Helfet; T Howey; R Sanders; K Johansen
Journal:  Clin Orthop Relat Res       Date:  1990-07       Impact factor: 4.176

6.  Complex limb salvage or early amputation for severe lower-limb injury: a meta-analysis of observational studies.

Authors:  Jason W Busse; Craig L Jacobs; Marc F Swiontkowski; Michael J Bosse; Mohit Bhandari
Journal:  J Orthop Trauma       Date:  2007-01       Impact factor: 2.512

7.  Subatmospheric pressure dressing as a bridge to free tissue transfer in the treatment of open tibia fractures.

Authors:  Brian Rinker; Jonathan C Amspacher; Patrick C Wilson; Henry C Vasconez
Journal:  Plast Reconstr Surg       Date:  2008-05       Impact factor: 4.730

8.  Decision making and results in subtotal and total lower leg amputations: reconstruction versus amputation.

Authors:  R Hierner; A M Betz; J J Comtet; A C Berger
Journal:  Microsurgery       Date:  1995       Impact factor: 2.425

9.  Lower limb replantations: indications and a new scoring system.

Authors:  Bruno Battiston; Pierluigi Tos; Italo Pontini; Sebastiano Ferrero
Journal:  Microsurgery       Date:  2002       Impact factor: 2.425

  9 in total
  1 in total

1.  Effect of endogenous bone marrow derived stem cells induced by AMD-3100 on expanded ischemic flap.

Authors:  Hii-Sun Jeong; Hye-Kyung Lee; Kwan-Chul Tark; Dae-Hyun Lew; Yoon-Woo Koh; Chul-Hoon Kim; In-Suck Seo
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.